Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
Journal of Attention Disorders|May 19, 2025
Does Stimulant Medication Status Moderate the Association Between Attention-Deficit/Hyperactivity Disorder (ADHD) Symptoms and Rumination?Annie I Reiner, Alex J Greenberg, Matthew A Jarrett, et al.
JDS Communications|January 15, 2024
Hind feet position score: A novel trait to genetically reduce lameness incidenceA Köck, J Kofler, L Lemmens, et al.
Wiener Klinische Wochenschrift|December 31, 1997
Renal tolerability of four different once-daily dose regimen of netilmicin in critical care patientsK Laczika, T Staudinger, U Hollenstein, et al.
Biorxiv : the Preprint Server for Biology|December 12, 2025
Proteomic Analysis in Alzheimer's Disease with Psychosis Reveals Separate Molecular Signatures for Core AD Proteinopathy and Postsynaptic Density DisruptionT S Ku, S J Mullett, Z Sui, et al.
Frontiers in Psychiatry|May 23, 2024
Working memory and inhibitory control deficits in children with ADHD: an experimental evaluation of competing model predictionsMichael J Kofler, Nicole B Groves, Elizabeth S M Chan, et al.
Research on Child and Adolescent Psychopathology|December 29, 2023
Does Anxiety Systematically Bias Estimates of Executive Functioning Deficits in Pediatric Attention-Deficit/Hyperactivity Disorder?Carolyn L Marsh, Sherelle L Harmon, Sooyun Cho, et al.
Communications Biology|June 2, 2023
Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer DiseaseJ M Krivinko, M R DeChellis-Marks, L Zeng, et al.
Journal of Clinical Anesthesia|October 12, 2000
Prostaglandin E(1) does not influence plasmatic coagulation, hepatic synthesis, or postoperative blood loss in patients after coronary-artery bypass graftingG J Locker, M Grimm, H Losert, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 21, 2023
Nivolumab for locally advanced and metastatic cutaneous squamous cell carcinoma (NIVOSQUACS study)-Phase II data covering impact of concomitant haematological malignanciesR Lang, T Welponer, E Richtig, et al.
British Journal of Haematology|November 11, 1999
Activation of endothelium by immunotherapy with interleukin-2 in patients with malignant disordersG J Locker, S Kapiotis, M Veitl, et al.
Pageof 19